Grant of Options to Director

RNS Number : 2799C

NetScientific PLC

27 June 2016

 

("NetScientific" or the "Company" or the "Group")

Grant of Options to Director

London, UK - 27^th June 2016 - NetScientific plc ("NetScientific", AIM: NSCI), the transatlantic biomedical and healthcare technology group, today announced that on 24^th June 2016, options over ordinary shares of 5p each were granted to Ian Postlethwaite and Stephen Smith as detailed below.

Ian Postlethwaite joined the Company on the 13^th June 2016 as Chief Financial Officer, joining the Board immediately following the Company's Annual General Meeting on 15^th June 2016. Stephen Smith joined the Company on 17^th of February 2016 as a Non-Executive Director.

Director	Number of Options       Granted	Number of Options Held
Ian Postlethwhaite	180,000	180,000
Stephen Smith	30,000	30,000

The options have an exercise price of 79.70 pence per share, being the average closing price for the ordinary shares over the five dealing days prior to the date on which the options were granted. The options granted to Ian Postlethwaite and Stephen Smith vest on 13^th June 2019 and 17^th February 2019 respectively, being three years from the dates they joined the Company.

- Ends -

For more information, please contact:

NetScientific François R. Martelet, M.D., CEO Ian Postlethwaite, CFO	Tel: [phone]
Investec (NOMAD and broker) Gary Clarence / Daniel Adams	Tel: [phone]
Consilium Strategic Communications Mary-Jane Elliott / Chris Gardner / Jessica Hodgson / Chris Welsh / Laura Thornton	Tel: [phone] [e-mail]

About NetScientific Plc

NetScientific is a biomedical and healthcare technology group that funds and develops technologies that offer transformative benefits to people's lives and society through improved diagnosis, prognosis and treatment.  For more information, please visit the website at www.netscientific.net.

 

END

 

 

DSHFQLLLQQFEBBE